661
Views
12
CrossRef citations to date
0
Altmetric
Review

Biological measures to minimize the risk of radiotherapy-associated second cancer: A research perspective

, , , , , , , , , , , & show all
Pages 289-301 | Received 12 Sep 2015, Accepted 04 Feb 2016, Published online: 11 Mar 2016

References

  • Aldaz CM, Liao QY, LaBate M, Johnston DA. 1996. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis. 17:2069–2072.
  • Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, et al. 2010. Control of mammary stem cell function by steroid hormone signalling. Nature. 465:798–802.
  • Barton M, Santucci-Pereira J, Russo J. 2014. Molecular pathways involved in pregnancy-induced prevention against breast cancer. Front Endocrinol (Lausanne). 5:213.
  • Baten A, Ullah A, Tomazic VJ, Shamsuddin AM. 1989. Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis. 10:1595–1598.
  • Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E. 2011. Proportion of second cancers attributable to radiotherapy treatment in adults: A cohort study in the US SEER cancer registries. Lancet Oncol. 12:353–360.
  • Bhatti P, Struewing JP, Alexander BH, Hauptmann M, Bowen L, Mateus-Pereira LH, Pineda MA, Simon SL, Weinstock RM, Rosenstein M, et al. 2008. Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists. Int J Cancer. 122:177–182.
  • Boaventura P, Pereira D, Mendes A, Batista R, da Silva AF, Guimaraes I, Honavar M, Teixeira-Gomes J, Lopes JM, Maximo V, et al. 2014. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas. J Dermatol Sci. 73:31–39.
  • Broeks A, Braaf LM, Wessels LF, van de Vijver M, De Bruin ML, Stovall M, Russell NS, van Leeuwen FE, Van’t Veer LJ. 2010. Radiation-associated breast tumors display a distinct gene expression profile. Int J Radiat Oncol Biol Phys. 76:540–547.
  • Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, et al. 2012. Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Hum Mutat. 33:158–164.
  • Buc-Calderon P, Defresne MP, Barvais C, Roberfroid M. 1989. N-acyl dehydroalanines protect from radiation toxicity and inhibit radiation carcinogenesis in mice. Carcinogenesis. 10:1641–1644.
  • Bump EA, Malaker K. 1997. Chemical, biological, and clinical perspectives. Boca Raton, FL: CRC Press.
  • Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, et al. 2005. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst. 97:724–732.
  • Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, Goodman P, Stovall M, Robison LL, Hudson MM. 2011. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study. Blood. 117:1806–1816.
  • Castiglioni F, Terenziani M, Carcangiu ML, Miliano R, Aiello P, Bertola L, Triulzi T, Gasparini P, Camerini T, Sozzi G, et al. 2007. Radiation effects on development of HER2-positive breast carcinomas. Clin Cancer Res. 13:46–51.
  • Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, et al. 2007. Second cancers among 104,760 survivors of cervical cancer: Evaluation of long-term risk. J Natl Cancer Inst. 99:1634–1643.
  • Clifton KH, Tanner MA, Gould MN. 1986. Assessment of radiogenic cancer initiation frequency per clonogenic rat mammary cell in vivo. Cancer Res. 46:2390–2395.
  • Cucinotta FA, Durante M. 2006. Cancer risk from exposure to galactic cosmic rays: Implications for space exploration by human beings. Lancet Oncol. 7:431–435.
  • Daino K, Ugolin N, Altmeyer-Morel S, Guilly MN, Chevillard S. 2009. Gene expression profiling of alpha-radiation-induced rat osteosarcomas: Identification of dysregulated genes involved in radiation-induced tumorigenesis of bone. Int J Cancer. 125:612–620.
  • Dange P, Sarma H, Pandey BN, Mishra KP. 2007. Radiation-induced incidence of thymic lymphoma in mice and its prevention by antioxidants. J Environ Pathol Toxicol Oncol. 26:273–279.
  • Das DK, Chakraborty A, Sinha M, Manna K, Mukherjee D, Bhattacharjee S, Dey S. 2013. Modulatory role of quercetin against gamma radiation-mediated biochemical and morphological alterations of red blood cells. Int J Radiat Biol. 89:471–481.
  • Doi K, Mieno MN, Shimada Y, Yonehara H, Yoshinaga S. 2011. Meta-analysis of second cancer risk after radiotherapy among childhood cancer survivors. Radiat Prot Dosimetry. 146:263–267.
  • Doi K, Mieno MN, Shimada Y, Yonehara H, Yoshinaga S. 2014. Methodological extensions of meta-analysis with excess relative risk estimates: Application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy. J Radiat Res. 55:885–901.
  • Fabre A, Fournier A, Mesrine S, Desreux J, Gompel A, Boutron-Ruault MC, Clavel-Chapelon F. 2007. Oral progestagens before menopause and breast cancer risk. Br J Cancer. 96:841–844.
  • Fabre A, Fournier A, Mesrine S, Gompel A, Desreux J, Berrino F, Boutron-Ruault MC, Romieu I, Clavel-Chapelon F. 2008. Progestagens use before menopause and breast cancer risk according to histology and hormone receptors. Cancer Epidemiol Biomarkers Prev. 17:2723–2728.
  • Fenech MF. 2010. Nutriomes and nutrient arrays – the key to personalised nutrition for DNA damage prevention and cancer growth control. Genome Integr. 1:11.
  • Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. 2010. Subsequent neoplasms in 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst. 102:1083–1095.
  • Fuchs-Tarlovsky V. 2013. Role of antioxidants in cancer therapy. Nutrition. 29:15–21.
  • Furukawa K, Preston DL, Lonn S, Funamoto S, Yonehara S, Matsuo T, Egawa H, Tokuoka S, Ozasa K, Kasagi F, et al. 2010. Radiation and smoking effects on lung cancer incidence among atomic bomb survivors. Radiat Res. 174:72–82.
  • Gasser S, Orsulic S, Brown EJ, Raulet DH. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 436:1186–1190.
  • Goodwin PJ, Stambolic V. 2011. Obesity and insulin resistance in breast cancer – chemoprevention strategies with a focus on metformin. Breast. 20(Suppl. 3):S31–S35.
  • Grant EJ, Ozasa K, Preston DL, Suyama A, Shimizu Y, Sakata R, Sugiyama H, Pham TM, Cologne J, Yamada M, et al. 2012. Effects of radiation and lifestyle factors on risks of urothelial carcinoma in the Life Span Study of atomic bomb survivors. Radiat Res. 178:86–98.
  • Grdina DJ, Carnes BA, Grahn D, Sigdestad CP. 1991. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 51:4125–4130.
  • Hall EJ, Giaccia AJ. 2012. Radiobiology for the radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins.
  • Herranz M, Martin-Caballero J, Fraga MF, Ruiz-Cabello J, Flores JM, Desco M, Marquez V, Esteller M. 2006. The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma. Blood. 107:1174–1177.
  • Hill CK, Nagy B, Peraino C, Grdina DJ. 1986. 2-[(Aminopropyl)amino]ethanethiol (WR1065) is anti-neoplastic and anti-mutagenic when given during 60Co gamma-ray irradiation. Carcinogenesis. 7:665–668.
  • Hodgson DC. 2011. Late effects in the era of modern therapy for Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2011:323–329.
  • Hu JJ, Smith TR, Miller MS, Lohman K, Case LD. 2002. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen. 39:208–215.
  • Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA. 2012. Obesity, energy balance, and cancer: New opportunities for prevention. Cancer Prev Res (Phila). 5:1260–1272.
  • Imaoka T, Hisatsune H, Sakanishi Y, Nishimura Y, Nishimura M, Shimada Y. 2012. Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. J Endocrinol Invest. 35:828–834.
  • Imaoka T, Nishimura M, Daino K, Kokubo T, Doi K, Iizuka D, Nishimura Y, Okutani T, Takabatake M, Kakinuma S, et al. 2013. Influence of age on the relative biological effectiveness of carbon ion radiation for induction of rat mammary carcinoma. Int J Radiat Oncol Biol Phys. 85:1134–1140.
  • Imaoka T, Nishimura M, Kakinuma S, Hatano Y, Ohmachi Y, Kawano A, Maekawa A, Shimada Y. 2007. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations. Int J Radiat Oncol Biol Phys. 69:194–203.
  • Imaoka T, Yamashita S, Nishimura M, Kakinuma S, Ushijima T, Shimada Y. 2008. Gene expression profiling distinguishes between spontaneous and radiation-induced rat mammary carcinomas. J Radiat Res (Tokyo). 49:349–360.
  • Inano H, Onoda M. 2002. Radioprotective action of curcumin extracted from Curcuma longa LINN: Inhibitory effect on formation of urinary 8-hydroxy-2′-deoxyguanosine, tumorigenesis, but not mortality, induced by gamma-ray irradiation. Int J Radiat Oncol Biol Phys. 53:735–743.
  • Inano H, Onoda M. 2005. Nitric oxide produced by inducible nitric oxide synthase is associated with mammary tumorigenesis in irradiated rats. Nitric Oxide. 12:15–20.
  • Inano H, Onoda M, Inafuku N, Kubota M, Kamada Y, Osawa T, Kobayashi H, Wakabayashi K. 2000a. Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis. 21:1835–1841.
  • Inano H, Onoda M, Suzuki K, Kobayashi H, Wakabayashi K. 2000b. Inhibitory effects of WR-2721 and cysteamine on tumor initiation in mammary glands of pregnant rats by radiation. Radiat Res. 153:68–74.
  • Inano H, Onoda M, Suzuki K, Kobayashi H, Wakabayashi K. 2000c. Prevention of radiation-induced mammary tumours in rats by combined use of WR-2721 and tamoxifen. Int J Radiat Biol. 76:1113–1120.
  • Inskip PD, Ries LAG, Cohen RJ, Curtis RE. 2006. New malignancies following childhood cancer. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr, editors. New malignancies among cancer survivors: SEER Cancer Registries, 1973–2000. Bethesda, Maryland: NIH Pub. No. 05-5302. National Cancer Institute. pp 465–482.
  • Ishida Y, Takabatake T, Kakinuma S, Doi K, Yamauchi K, Kaminishi M, Kito S, Ohta Y, Amasaki Y, Moritake H, et al. 2010. Genomic and gene expression signatures of radiation in medulloblastomas after low-dose irradiation in Ptch1 heterozygous mice. Carcinogenesis. 31:1694–1701.
  • Jawad M, Giotopoulos G, Cole C, Plumb M. 2007. Target cell frequency is a genetically determined risk factor in radiation leukaemogenesis. Br J Radiol. 80SpecNo1:S56–62.
  • Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R. 2010. Progesterone induces adult mammary stem cell expansion. Nature. 465:803–807.
  • Kagimoto O, Naganuma A, Imura N, Toge T, Niwa O, Yokoro K. 1991. Effect of the administration of bismuth nitrate on radiogenic thymoma induction in mice. J Radiat Res. 32:417–428.
  • Kamiya K, Clifton KH, Gould MN, Yokoro K. 1991. Control of ductal vs. alveolar differentiation of mammary clonogens and susceptibility to radiation-induced mammary cancer. J Radiat Res. 32(Suppl. 2):181–194.
  • Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. 2008. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 26:392–398.
  • Kim JG, Park MT, Heo K, Yang KM, Yi JM. 2013. Epigenetics meets radiation biology as a new approach in cancer treatment. Int J Mol Sci. 14:15059–15073.
  • Kitahashi T, Takahashi M, Yamada Y, Oghiso Y, Yokohira M, Imaida K, Tsutsumi M, Takasuka N, Sugimura T, Wakabayashi K. 2008. Occurrence of mutations in the epidermal growth factor receptor gene in X-ray-induced rat lung tumors. Cancer Sci. 99:241–245.
  • Kodama Y, Noda A, Booth C, Breault D, Suda T, Hendry J, Shinohara T, Rube C, Nishimura EK, Mitani H, et al. 2012. International workshop: Radiation effects on mutation in somatic and germline stem cells. Int J Radiat Biol. 88:501–506.
  • Koide K, Osman S, Garner AL, Song F, Dixon T, Greenberger JS, Epperly MW. 2011. The use of 3,5,4′-tri-o-acetylresveratrol as a potential pro-drug for resveratrol protects mice from gamma-irradiation-induced death. ACS Med Chem Lett. 2:270–274.
  • Kunzmann A, Dedoussis G, Jajte J, Malavolta M, Mocchegiani E, Burkle A. 2008. Effect of zinc on cellular poly(ADP-ribosyl)ation capacity. Exp Gerontol. 43:409–414.
  • Lakshmanaswamy R, Guzman RC, Nandi S. 2008. Hormonal prevention of breast cancer: Significance of promotional environment. Adv Exp Med Biol. 617:469–475.
  • Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, Tokunaga M. 1994. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control. 5:167–176.
  • Land CE, Saku T, Hayashi Y, Takahara O, Matsuura H, Tokuoka S, Tokunaga M, Mabuchi K. 1996. Incidence of salivary gland tumors among atomic bomb survivors, 1950–1987. Evaluation of radiation-related risk. Radiat Res. 146:28–36.
  • Land CE, Shimosato Y, Saccomanno G, Tokuoka S, Auerbach O, Tateishi R, Greenberg SD, Nambu S, Carter D, Akiba S, et al. 1993. Radiation-associated lung cancer: A comparison of the histology of lung cancers in uranium miners and survivors of the atomic bombings of Hiroshima and Nagasaki. Radiat Res. 134:234–243.
  • Lee HJ, Lee YJ, Kang CM, Bae S, Jeoung D, Jang JJ, Lee SS, Cho CK, Lee YS. 2008. Differential gene signatures in rat mammary tumors induced by DMBA and those induced by fractionated gamma radiation. Radiat Res. 170:579–590.
  • Lemon HM, Kumar PF, Peterson C, Rodriguez-Sierra JF, Abbo KM. 1989. Inhibition of radiogenic mammary carcinoma in rats by estriol or tamoxifen. Cancer. 63:1685–1692.
  • Little MP, Weiss HA, Boice JD Jr, Darby SC, Day NE, Muirhead CR. 1999. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiat Res. 152:280–292.
  • Lupo B, Trusolino L. 2014. Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited. Biochim Biophys Acta. 1846:201–215.
  • Maeda J, Roybal EJ, Brents CA, Uesaka M, Aizawa Y, Kato TA. 2014. Natural and glucosyl flavonoids inhibit poly(ADP-ribose) polymerase activity and induce synthetic lethality in BRCA mutant cells. Oncol Rep. 31:551–556.
  • Maier P, Wenz F, Herskind C. 2014. Radioprotection of normal tissue cells. Strahlenther Onkol. 190:745–752.
  • Matsumoto K, Nakanishi I, Ueno M, Anzai K. 2012. Density of hydroxyl radical generated in an aqueous solution irradiated by carbon ion beam. Free Radic Biol Med. 53:S204–S205.
  • Meier-Abt F, Bentires-Alj M, Rochlitz C. 2015. Breast cancer prevention: Lessons to be learned from mechanisms of early pregnancy-mediated breast cancer protection. Cancer Res. 75:803–807.
  • Merrifield M, Kovalchuk O. 2013. Epigenetics in radiation biology: A new research frontier. Front Genet. 4:40.
  • Milas L, Hunter N, Stephens LC, Peters LJ. 1984. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 44:5567–5569.
  • Miller MS, Moore JE, Walb MC, Kock ND, Attia A, Isom S, McBride JE, Munley MT. 2013. Chemoprevention by N-acetylcysteine of low-dose CT-induced murine lung tumorigenesis. Carcinogenesis. 34:319–324.
  • Mitchell JB, Anver MR, Sowers AL, Rosenberg PS, Figueroa M, Thetford A, Krishna MC, Albert PS, Cook JA. 2012. The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation. Cancer Res. 72:4846–4855.
  • Morioka T, Miyoshi-Imamura T, Blyth BJ, Kaminishi M, Kokubo T, Nishimura M, Kito S, Tokairin Y, Tani S, Murakami-Murofushi K, et al. 2014. Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice. Cancer Sci. 106:217–226.
  • Murthy NS, Mukherjee S, Ray G, Ray A. 2009. Dietary factors and cancer chemoprevention: An overview of obesity-related malignancies. J Postgrad Med. 55:45–54.
  • Nambiar D, Rajamani P, Singh RP. 2011. Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutat Res. 728:139–157.
  • National Council on Radiation Protection and Measurements (NCRP). 2012. Second primary cancers and cardiovascular disease after radiation therapy. Bethesda: NCRP.
  • National Research Council (NRC). 1999. Health effects of exposure to radon: BEIR VI. Washington, DC: National Academy Press.
  • National Research Council (NRC). 2006. Health risks from exposure to low levels of ionizing radiation. BEIR VII, Phase 2. Washington (DC): The National Academic Press.
  • Neta G, Anderson WF, Gilbert E, Berrington A. 2012. Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER. Breast Cancer Res Treat. 131:1021–1027.
  • Newhauser WD, Durante M. 2011. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer. 11:438–448.
  • Nguyen DH, Fredlund E, Zhao W, Perou CM, Balmain A, Mao JH, Barcellos-Hoff MH. 2013. Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes. Clin Cancer Res. 19:1353–1362.
  • Niwa O. 2010. Roles of stem cells in tissue turnover and radiation carcinogenesis. Radiat Res. 174:833–839.
  • Norat T, Aune D, Chan D, Romaguera D. 2014. Fruits and vegetables: Updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention. Cancer Treat Res. 159:35–50.
  • Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Tsuge M, Chayama K. 2011. Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma. Hepatology. 53:1237–1245.
  • Oike T, Ogiwara H, Nakano T, Kohno T. 2013. Histone acetyltransferases (HATs) involved in non-homologous end joining as a target for radiosensitization. In: Kataria T, editor. Frontiers in radiation oncology. Rijeka: InTech. pp 3–12.
  • Oliai C, Yang LX. 2014. Radioprotectants to reduce the risk of radiation-induced carcinogenesis. Int J Radiat Biol. 90:203–213.
  • Ong TP, Moreno FS, Ross SA. 2011. Targeting the epigenome with bioactive food components for cancer prevention. J Nutrigenet Nutrigenomics. 4:275–292.
  • Peterson NC, Servinsky MD, Christian A, Peng Z, Qiu W, Mann J, Dicello J, Huso DL. 2005. Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model. Carcinogenesis. 26:1542–1552.
  • Pothuri B, Ramondetta L, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA. 2006. Radiation-associated endometrial cancers are prognostically unfavorable tumors: A clinicopathologic comparison with 527 sporadic endometrial cancers. Gynecol Oncol. 103:948–951.
  • Rajaraman P, Bhatti P, Doody MM, Simon SL, Weinstock RM, Linet MS, Rosenstein M, Stovall M, Alexander BH, Preston DL, et al. 2008. Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists. Int J Cancer. 123:2713–2716.
  • Rastogi L, Feroz S, Pandey BN, Jagtap A, Mishra KP. 2010. Protection against radiation-induced oxidative damage by an ethanolic extract of Nigella sativa L. Int J Radiat Biol. 86:719–731.
  • Riggins RB, Schrecengost RS, Guerrero MS, Bouton AH. 2007. Pathways to tamoxifen resistance. Cancer Lett. 256:1–24.
  • Rivina L, Schiestl R. 2013. Mouse models for efficacy testing of agents against radiation carcinogenesis – a literature review. Int J Environ Res Public Health. 10:107–143.
  • Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, et al. 2009. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 113:1175–1183.
  • Ron E, Preston DL, Kishikawa M, Kobuke T, Iseki M, Tokuoka S, Tokunaga M, Mabuchi K. 1998. Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes Control. 9:393–401.
  • Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. 2010. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 10:293–301.
  • Sachs RK, Brenner DJ 2005. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci USA. 102:13040–13045.
  • Sandhya T, Lathika KM, Pandey BN, Bhilwade HN, Chaubey RC, Priyadarsini KI, Mishra KP. 2006. Protection against radiation oxidative damage in mice by Triphala. Mutat Res. 609:17–25.
  • Santucci-Pereira J, George C, Armiss D, Russo IH, Vanegas JE, Sheriff F, de Cicco RL, Su Y, Russo PA, Bidinotto LT, et al. 2013. Mimicking pregnancy as a strategy for breast cancer prevention. Breast Cancer Manag. 2:283–294.
  • Sauvaget C, Kasagi F, Waldren CA. 2004. Dietary factors and cancer mortality among atomic-bomb survivors. Mutat Res. 551:145–152.
  • Schwabe RF, Jobin C. 2013. The microbiome and cancer. Nat Rev Cancer. 13:800–812.
  • Sekine-Suzuki E, Nakanishi I, Shimokawa T, Ueno M, Matsumoto K, Murakami T. 2013. High-throughput screening of radioprotectors using rat thymocytes. Anal Chem. 85:7650–7653.
  • Selmansberger M, Feuchtinger A, Zurnadzhy L, Michna A, Kaiser JC, Abend M, Brenner A, Bogdanova T, Walch A, Unger K, et al. 2014. CLIP2 as radiation biomarker in papillary thyroid carcinoma. Oncogene. 34:3917–3925.
  • Shang Y, Kakinuma S, Yamauchi K, Morioka T, Kokubo T, Tani S, Takabatake T, Kataoka Y, Shimada Y. 2014. Cancer prevention by adult-onset calorie restriction after infant exposure to ionizing radiation in B6C3F1 male mice. Int J Cancer. 135:1038–1047.
  • Sharp GB, Mizuno T, Cologne JB, Fukuhara T, Fujiwara S, Tokuoka S, Mabuchi K. 2003. Hepatocellular carcinoma among atomic bomb survivors: Significant interaction of radiation with hepatitis C virus infections. Int J Cancer. 103:531–537.
  • Shimizu M, Takai K, Moriwaki H. 2009. Strategy and mechanism for the prevention of hepatocellular carcinoma: Phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention. Cancer Sci. 100:369–374.
  • Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS. 2002. Skin cancer after X-ray treatment for scalp ringworm. Radiat Res. 157:410–418.
  • Smith RE, Good BC. 2003. Chemoprevention of breast cancer and the trials of the National Surgical Adjuvant Breast and Bowel Project and others. Endocr Relat Cancer. 10:347–357.
  • Takahashi H, Hosono K, Endo H, Nakajima A. 2013. Colon epithelial proliferation and carcinogenesis in diet-induced obesity. J Gastroenterol Hepatol. 28(Suppl 4):41–47.
  • Tarapore RS, Siddiqui IA, Mukhtar H. 2012. Modulation of Wnt/beta-catenin signaling pathway by bioactive food components. Carcinogenesis. 33:483–491.
  • Tawfik SS, Abouelella AM, Shahein YE. 2013. Curcumin protection activities against gamma-rays-induced molecular and biochemical lesions. BMC Res Notes. 6:375.
  • Thorat MA, Cuzick J. 2013. Role of aspirin in cancer prevention. Curr Oncol Rep. 15:533–540.
  • Tiwari P, Kumar A, Ali M, Mishra KP. 2010. Radioprotection of plasmid and cellular DNA and Swiss mice by silibinin. Mutat Res. 695:55–60.
  • Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. 2013. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol. 10:289–301.
  • Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, et al. 2012. Second malignant neoplasms and cardiovascular disease following radiotherapy. J Natl Cancer Inst. 104:357–370.
  • Trichopoulos D, Lagiou P, Adami HO. 2005. Towards an integrated model for breast cancer etiology: The crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res. 7:13–17.
  • Tsuji H, Ishii-Ohba H, Ukai H, Katsube T, Ogiu T. 2003. Radiation-induced deletions in the 5′ end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas. Carcinogenesis. 24:1257–1268.
  • Turrin A, Pilotti S, Ricci SB. 1985. Characteristics of thyroid cancer following irradiation. Int J Radiat Oncol Biol Phys. 11:2149–2154.
  • Tyson J, Mathers JC. 2007. Dietary and genetic modulation of DNA repair in healthy human adults. Proc Nutr Soc. 66:42–51.
  • Ueno M, Inano H, Onoda M, Murase H, Ikota N, Kagiya TV, Anzai K. 2009. Modification of mortality and tumorigenesis by tocopherol-mono-glucoside (TMG) administered after X irradiation in mice and rats. Radiat Res. 172:519–524.
  • Uma Devi P, Satyamitra M. 2004. Protection against prenatal irradiation-induced genomic instability and its consequences in adult mice by Ocimum flavonoids, orientin and vicenin. Int J Radiat Biol. 80:653–662.
  • United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). 2008. Sources and effects of ionizing radiation: 2008 Report to the General Assembly, with Scientific Annexes. New York: United Nations.
  • Uray IP, Brown PH. 2011. Chemoprevention of hormone receptor-negative breast cancer: New approaches needed. Recent Results Cancer Res. 188:147–162.
  • Vinayak S, Ford JM. 2010. PARP inhibitors for the treatment and prevention of breast cancer. Curr Breast Cancer Rep. 2:190–197.
  • Wei Q, Shen H, Wang LE, Duphorne CM, Pillow PC, Guo Z, Qiao Y, Spitz MR. 2003. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev. 12:963–969.
  • Weiss JF, Landauer MR. 2009. History and development of radiation-protective agents. Int J Radiat Biol. 85:539–573.
  • Wood ME, Vogel V, Ng A, Foxhall L, Goodwin P, Travis LB. 2012. Second malignant neoplasms: Assessment and strategies for risk reduction. J Clin Oncol. 30:3734–3745.
  • Yoshida K, Hirabayashi Y, Watanabe F, Sado T, Inoue T. 2006. Caloric restriction prevents radiation-induced myeloid leukemia in C3H/HeMs mice and inversely increases incidence of tumor-free death: Implications in changes in number of hemopoietic progenitor cells. Exp Hematol. 34:274–283.
  • Yoshida K, Inoue T, Nojima K, Hirabayashi Y, Sado T. 1997. Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice. Proc Natl Acad Sci USA. 94:2615–2619.
  • Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et al. 2013. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 499:97–101.
  • Yue W, Yang CS, DiPaola RS, Tan XL. 2014. Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment. Cancer Prev Res (Phila). 7:388–397.
  • Zhao L, Zhou C, Zhang J, Gao F, Li B, Chuai Y, Liu C, Cai J. 2011. Hydrogen protects mice from radiation induced thymic lymphoma in BALB/c mice. Int J Biol Sci. 7:297–300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.